Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Ivonne Regel"'
Autor:
Marlies Vornhülz, Sofia Anton, Balint Eross, Zsolt Szakács, Peter Hegyi, Ivonne Regel, Claus Belka, Maximilian Niyazi, Julia Mayerle, Georg Beyer
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-10 (2022)
Abstract Introduction Up to 30% of pancreatic cancer patients initially present locally advanced (LAPC). Stereotactic body radiation therapy (SBRT) may be an additional palliative treatment option when curative resection is no longer achievable. Our
Externí odkaz:
https://doaj.org/article/02eaf26bf2c34a1a915f91752b223584
Autor:
Hao Lin, Yuhui Fan, Andreas Wieser, Jiang Zhang, Ivonne Regel, Hanno Nieß, Julia Mayerle, Alexander L. Gerbes, Christian J. Steib
Publikováno v:
Cells, Vol 10, Iss 9, p 2298 (2021)
Chronic liver diseases (CLDs) are complex diseases that cause long-term inflammation and infection, which in turn accelerate their development. The usage of albumin in patients with CLDs has been debated for years. Human serum albumin (HSA) plays a k
Externí odkaz:
https://doaj.org/article/75278de5a4f24adbbca8dbb960945fa1
Autor:
Ujjwal Mukund Mahajan, Ahmed Alnatsha, Qi Li, Bettina Oehrle, Frank-Ulrich Weiss, Matthias Sendler, Marius Distler, Waldemar Uhl, Tim Fahlbusch, Elisabetta Goni, Georg Beyer, Ansgar Chromik, Markus Bahra, Fritz Klein, Christian Pilarsky, Robert Grützmann, Markus M. Lerch, Kirsten Lauber, Nicole Christiansen, Beate Kamlage, Ivonne Regel, Julia Mayerle
Publikováno v:
Cells, Vol 10, Iss 7, p 1821 (2021)
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Developing biomarkers for early detection and chemotherapeutic response prediction is crucial to improve the dismal prognosis of PDAC patients. However, molecular cancer signatu
Externí odkaz:
https://doaj.org/article/058912f1cab749e89badfcbf8c663230
Autor:
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel
Publikováno v:
Cancers, Vol 12, Iss 11, p 3234 (2020)
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a dismal prognosis that is frequently diagnosed at an advanced stage. Although less common than other malignant diseases, it currently ranks as the fourth most common cause of canc
Externí odkaz:
https://doaj.org/article/898a603cce7447d197d1cfbad1809962
Publikováno v:
Cancers, Vol 12, Iss 4, p 1024 (2020)
Current standard-of-care for patients with pancreatic ductal adenocarcinoma (PDAC) focusses on chemotherapeutic regimens and pancreatic cancer surgery. However, limited treatment options, late diagnosis in advanced tumor stages and the aggressive beh
Externí odkaz:
https://doaj.org/article/06555bedb498424196852552e0b8c008
Autor:
Katharina J Miller, Susanne Raulefs, Bo Kong, Katja Steiger, Ivonne Regel, Andreas Gewies, Jörg Kleeff, Christoph W Michalski
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0143735 (2015)
Type I interferon constitutes an essential component of the combinational therapy against viral disease. Acute pancreatitis is one side effect of type I interferon-based therapy, implying that activation of type I interferon signaling affects the hom
Externí odkaz:
https://doaj.org/article/df282f41aae54b7db2f3c2ae22113df6
Autor:
Ujjwal M. Mahajan, Bettina Oehrle, Simon Sirtl, Ahmed Alnatsha, Elisabetta Goni, Ivonne Regel, Georg Beyer, Marlies Vornhülz, Jakob Vielhauer, Ansgar Chromik, Markus Bahra, Fritz Klein, Waldemar Uhl, Tim Fahlbusch, Marius Distler, Jürgen Weitz, Robert Grützmann, Christian Pilarsky, Frank Ulrich Weiss, M. Gordian Adam, John P. Neoptolemos, Holger Kalthoff, Roland Rad, Nicole Christiansen, Bianca Bethan, Beate Kamlage, Markus M. Lerch, Julia Mayerle
Publikováno v:
Gastroenterology. 163:1407-1422
Pancreatic ductal adenocarcinoma cancer (PDAC) is a highly lethal malignancy requiring efficient detection when the primary tumor is still resectable. We previously developed the MxPancreasScore comprising 9 analytes and serum carbohydrate antigen 19
Autor:
Jody Vykoukal, Eckhard Alt, Jaime Rodriguez, Ignacio I. Wistuba, Christoph W. Michalski, Kenji Yokoi, Ivonne Regel, Alejandro Recio Boiles, Matthias Ilmer
Cancer stem cells (CSC) present a formidable clinical challenge by escaping therapeutic intervention and seeding tumors through processes that remain incompletely understood. Here, we describe small subpopulations of pancreatic cancer cells with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd7134da75e63d692eb55610ed5775c
https://doi.org/10.1158/0008-5472.c.6507092
https://doi.org/10.1158/0008-5472.c.6507092
Autor:
Jody Vykoukal, Eckhard Alt, Jaime Rodriguez, Ignacio I. Wistuba, Christoph W. Michalski, Kenji Yokoi, Ivonne Regel, Alejandro Recio Boiles, Matthias Ilmer
Supplemental Table S2. List of murine primer sequences used in qRT-PCR analysis in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01948dce238f210875017ba562ae10f6
https://doi.org/10.1158/0008-5472.22406516
https://doi.org/10.1158/0008-5472.22406516
Autor:
Jody Vykoukal, Eckhard Alt, Jaime Rodriguez, Ignacio I. Wistuba, Christoph W. Michalski, Kenji Yokoi, Ivonne Regel, Alejandro Recio Boiles, Matthias Ilmer
Supplemental Table and Figure Legends. Legends for Supplemental Tables S1-S5 and Supplemental Figures S1-S8.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70be1782df2603b9930302dc3b8e03b0
https://doi.org/10.1158/0008-5472.22406489
https://doi.org/10.1158/0008-5472.22406489